Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Spectral Medical Inc > Paradigm needs to update…
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(859)
•••
Comment by mercedesmanon Jul 24, 2022 9:58pm
178 Views
Post# 34847079

RE:RE:Paradigm needs to update…

RE:RE:Paradigm needs to update…

Ssob 

Paradigm has issued at least two updates since then 

they lowered the target price due to trial delays/ COVID, yada yada 

I see the latest release as being out of step with recent positive announcements. 

Ali can probably get you a little more current. 


But Gorf is likely right. There is (1) the SP, (2) the reality, with the latest developments and LT prospects fully factored in, and (3) an out of step Analyst. 


MM 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities